{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T05:22:55Z","timestamp":1788326575696,"version":"build-2803163510"},"reference-count":18,"publisher":"The Journal of Rheumatology","issue":"Suppl 3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"accepted":{"date-parts":[[2025,7,26]]},"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:p>Early recognition and appropriate management of cardiovascular (CV) disease (CVD) in patients with psoriatic disease (PsD) is critical for prevention of early morbidity and mortality. PsD and CVD share common pathogenic mechanisms, including upregulation of proinflammatory cytokines like tumor necrosis factor. Potential CV comorbidities should be assessed in all patients with PsD through clinical history, risk factor assessment (eg, diabetes, hypertension, dyslipidemia), blood tests, and imaging, when required. Collaboration with the patient\u2019s primary care physician is essential, offering preventive measures such as healthy lifestyle advice (eg, diet, exercise, weight loss, smoking and drinking cessation). Management of comorbid conditions requires a multidisciplinary setting of family doctors, internists, cardiologists, dermatologists, and rheumatologists. Treating psoriatic arthritis and psoriasis to remission is recommended; however, the data on CVD risk modification remain inconclusive, necessitating further studies. Thus, routine CVD assessment and management should be provided to patients with PsD, despite practical difficulties such as clinical time constraints and lack of support staff. The evidence and experiences of a dermatologist and rheumatologist assessing and managing CVD in clinic were presented at the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2024 annual meeting.<\/jats:p>","DOI":"10.3899\/jrheum.2025-0811","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T12:25:25Z","timestamp":1757939125000},"page":"49-51","source":"Crossref","is-referenced-by-count":1,"title":["How to Manage Cardiovascular Disease in Psoriatic Disease: Evidence and Time Management in Clinic"],"prefix":"10.3899","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0070-1945","authenticated-orcid":false,"given":"Maria-Angeliki","family":"Gkini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9630-5439","authenticated-orcid":false,"given":"Pamela","family":"D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5807-0445","authenticated-orcid":false,"given":"Cheryl F.","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3306-9699","authenticated-orcid":false,"given":"Claudia","family":"Goldenstein-Schainberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2025,9,15]]},"reference":[{"key":"2026090121551311000_52.Suppl_3.49.1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780401021"},{"key":"2026090121551311000_52.Suppl_3.49.2","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.3390\/ijms18102211","article-title":"Psoriasis and cardiovascular comorbidities: focusing on severe vascular events, cardiovascular risk factors and implications for treatment","volume":"18","author":"Hu","year":"2017","journal-title":"Int J Mol Sci"},{"key":"2026090121551311000_52.Suppl_3.49.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2011.05.022"},{"key":"2026090121551311000_52.Suppl_3.49.4","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.3390\/ijms24054901","article-title":"Psoriatic arthritis: pathogenesis and targeted therapies","volume":"24","author":"Azuaga","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2026090121551311000_52.Suppl_3.49.5","doi-asserted-by":"crossref","first-page":"835439","DOI":"10.3389\/fcvm.2022.835439","article-title":"Related risk factors and treatment management of psoriatic arthritis complicated with cardiovascular disease","volume":"9","author":"Zheng","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"2026090121551311000_52.Suppl_3.49.6","doi-asserted-by":"publisher","DOI":"10.1089\/met.2009.0124"},{"key":"2026090121551311000_52.Suppl_3.49.7","first-page":"182","article-title":"Hypertension and diabetes significantly enhance the risk of cardiovascular disease in patients with psoriatic arthritis","volume":"32","author":"Favarato","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"2026090121551311000_52.Suppl_3.49.8","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000678"},{"key":"2026090121551311000_52.Suppl_3.49.9","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2009.316"},{"key":"2026090121551311000_52.Suppl_3.49.10","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-022-00798-0"},{"key":"2026090121551311000_52.Suppl_3.49.11","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-016-8560-9"},{"key":"2026090121551311000_52.Suppl_3.49.12","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.cgh.2023.09.033","article-title":"Risk of major adverse cardiovascular events in immune-mediated inflammatory disorders on biologics and small molecules: network meta-analysis","volume":"22","author":"Mattay","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026090121551311000_52.Suppl_3.49.13","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/1756-185X.14603","article-title":"Impact of targeted therapies on the risk of cardiovascular events in patients with psoriasis and psoriatic arthritis: a systematic review and aggregate data meta-analysis of randomized controlled trials","volume":"26","author":"Cai","year":"2023","journal-title":"Int J Rheum Dis"},{"key":"2026090121551311000_52.Suppl_3.49.14","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1016\/j.jid.2021.03.024","article-title":"Impact of biological agents on imaging and biomarkers of cardiovascular disease in patients with psoriasis: a systematic review and meta-analysis of randomized placebo-controlled trials","volume":"141","author":"Gonz\u00e1lez-Cantero","year":"2021","journal-title":"J Invest Dermatol"},{"key":"2026090121551311000_52.Suppl_3.49.15","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/j.jacc.2021.02.009","article-title":"Cardiovascular risk in patients with psoriasis: JACC review topic of the week","volume":"77","author":"Garshick","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2026090121551311000_52.Suppl_3.49.16","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12024"},{"key":"2026090121551311000_52.Suppl_3.49.17","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2147\/PTT.S328572","article-title":"Comorbidity in adult psoriasis: considerations for the clinician","volume":"12","author":"Daugaard","year":"2022","journal-title":"Psoriasis"},{"key":"2026090121551311000_52.Suppl_3.49.18","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.jaad.2018.11.058","article-title":"Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities","volume":"80","author":"Elmets","year":"2019","journal-title":"J Am Acad Dermatol"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.2025-0811","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T04:55:38Z","timestamp":1788324938000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.2025-0811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,15]]},"references-count":18,"journal-issue":{"issue":"Suppl 3","published-online":{"date-parts":[[2025,12,1]]},"published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10.3899\/jrheum.2025-0811"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.2025-0811","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,15]]}}}